Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)

Author(s): Garcia-Carbonero R, Capdevila J, Crespo-Herrero G, Diaz-Perez JA, Martinez DPM, et al.

Abstract

Background

Neuroendocrine tumors (NETs) are an unusual family of neoplasms with a wide and complex spectrum of clinical behavior. Here, we present the first report of a National Cancer Registry of gastroenteropancreatic neuroendocrine tumors from a Southern European country.

Patients and methods

Data was provided online at www.retegep.net by participating centers and assessed for internal consistency by external independent reviewers.

Similar Articles

Neuroendocrine tumours of the gallbladder: three cases and a review of the literature

Author(s): Iype S, Mirza TA, Propper DJ, Bhattacharya S, Feakins RM, et al.

Two cases of small cell carcinoma of the gallbladder

Author(s): Nau P, Liu J, Dillhoff M, Forster M, Hazey J, et al.

Combined neuroendocrine cell carcinoma and adenocarcinoma of the gallbladder: A report of a case

Author(s): Shimizu T, Tajiri T, Akimaru K, Arima Y, Yoshida H, et al.

Neuroendocrine tumor epidemiology: contrasting Norway and North America

Author(s): Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

Author(s): Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, et al.

NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors

Author(s): Clark OH, Benson AR, Berlin JD, Choti MA, Doherty GM, et al.

Gastroenteropancreatic neuroendocrine tumours

Author(s): Modlin IM, Oberg K, Chung DC, Jensen RT, De Herder WW